2
+ ), and biliverdin (BV). Subsequently, BV is converted into bilirubin by a BV reductase, and the ferrous iron is rapidly sequestered by ferritin and recycled for heme synthesis. An inducible form of the two HO isozymes, HO-1, which is expressed under various pathological conditions, can metabolize a large amount of heme to produce high concentrations of its products that cause medically interesting biological effects. HO-1 expression is caused not only because of its substrate, free heme, but also because of a wide variety of pro-inflammatory stimuli, suggesting that HO-1, in addition to its fundamental role in heme degradation, plays other important roles in the resolution of inflammation. The biological action of HO-derived carbon monoxide (CO) is substantiated by the pharmacological effects observed when this gas is applied exogenously to in vitro and in vivo systems. In this regard, this review focused on the modulation of metabolism by CO, as well as inflammation and its roles in immunometabolism.
HO-1/CO IN METABOLIC DISEASES
Aggravation of metabolic health is generally assumed to be detrimental to longevity. Because obesity-related inflammatory responses are associated with metabolic diseases, immune responses and metabolic regulation are tightly linked. Obesity and metabolic inflammation are considered risk factors for age-related diseases, including diabetes, cancer, cardiovascular disease, and non-alcoholic fatty liver disease (NAFLD). Recently, CO was reported to induce the immune-regulator gene to generate itaconate, which shows immunosuppressive as well as antimicrobial functions in the tricarboxylic acid cycles of macrophages stimulated with lipopolysaccharide.
1 HO-1 deficiency accelerates obesity and vascular dysfunction associated with metabolic syndrome. 2 Endogenous or low-dose exogenous CO provides protective roles in the regulation of the stress response and in cell adaptation to injury. CO given to mice fed a high-fat diet (HFD) prevented the development of HFDinduced obesity. Furthermore, it was reported that metabolic syndrome is closely associated with cancer development and progression. CO was investigated for its anticancer activities mediated by regulation of the metabolic state, macrophage polarization, and extracellular signal-regulated kinases in various cancer cells or the tumor microenvironment. 3 However, further study is needed to understand the detailed mechanism of action. Thus, in a subsequent study of the involvement of CO in immunometabolism, we focused on several metabolic pathways that are regulated by the HO-1/CO system.
CO AND THE INTEGRATED STRESS RESPONSE IN METABOLIC HOMEOSTASIS
CO generates low levels of mitochondrial reactive oxygen species (mtROS), and this oxidative stress can lead to the activation of adaptive signaling pathways. 4 ROS generated by mitochondrial stress has been reported to activate the protein kinase-like endoplasmic reticulum (ER) kinase (PERK)/eukaryotic initiation factor-2 alpha (eIF2α)/activating transcription factor-4 (ATF4) signaling pathway. 5 This pathway promotes stress resistance, as well as cellular responses that can extend health and lifespan. Several publications demonstrated the involvement of ER stress in obesity-related diseases, verifying a role for the unfolded protein response (UPR) in this process. Activation of the UPR controls insulin signaling pathways. The close contacts between mitochondria and ER, known as mitochondriaassociated ER membranes (MAM), play a crucial role in the control of metabolic homeostasis. The disruption of proteins that are localized at the MAM interface influences signaling cascades involved in autophagy, UPR-, redox-, immune-, insulin-, and nutrient signaling, resulting in the impairment of metabolic homeostasis. In particular, PERK, one branch of the UPR found at the MAM, is involved in organelle tethering. 6 Loss of PERK reduced ER-mitochondria interactions and disrupted ER morphology and Ca 2+ signaling, thereby affecting MAM integrity. Therefore, the interplay between ROS induced by CO from mitochondria and PERK may be an important signaling hub for mitochondria-ER communication to treat metabolic diseases. In addition, heterozygous mice carrying the mutant form of eIF2α fed a HFD developed obesity and a phenotype of type 2 diabetes. Moreover, ATF4 associated with the regulation of both metabolic and redox processes plays a role in the regulation of metabolic homeostasis. ATF4 regulates a variety of cellular stresses, such as glucose or amino-acid starvation and ER stress through upregulation of SESN2 (sestrin 2) 7 , fibroblast growth factor 21 (FGF21) 8 , and regulated in development and DNA damage responses 1 (REDD1). 9 Our previous reports showed that CO induces ATF4-mediated HO-1 expression via the PERK-Nrf2 pathway. 10 Thus, the correlation of ER function with metabolic pathways related to obesity and diabetes drove us to explore the functions and mechanisms of CO in metabolic diseases. Our studies focused on the crosstalk between CO and metabolic disease through ATF4-mediated SESN2, FGF21, and REDD1 expression.
METABOLIC HOMEOSTASIS OF CO-INDUCED SESN2 Accumulating evidence indicates that in Sesn2
−/− mice, the progression of diverse age-and obesity-associated pathologies, including fat accumulation, insulin resistance, hepatosteatosis, cardiac dysfunction, and mitochondrial abnormalities, is exacerbated. Sesn2-deficient mice have autophagy impairment due to AMPK inhibition and mTORC1 activation upon diverse environmental stresses. We showed that CO ameliorates hepatic steatosis through the autophagy pathway induced by SESN2 upregulation. 11 CO not only generated mitochondrial ROS but also induced SESN2 expression by activating the PERK-dependent pathway. CO did not induce SESN2 expression in PERK −/− MEF, eIF2α A/A mutant hepatocytes, and ATF4 -/-hepatocytes, suggesting that the PERK branch may play a role in SESN2 induction. These responses were significantly inhibited by the ROS scavenger mitochondriatargeted antioxidant Mito-TEMPO. Moreover, CO induced SESN2 expression and enhanced autophagy through the AMPK/mTORC1 axis and attenuated steatohepatitis in mice fed a methioninecholine-deficient (MCD) diet. Knockdown of SESN2 in a cellular NAFLD model impaired autophagy and abolished the effects of CO on triglyceride levels.
METABOLIC HOMEOSTASIS OF CO-INDUCED FGF21
In addition to CO-induced SESN2, FGF21 is also involved in the protective effects of CO in HFD-induced obesity. FGF21 is an endocrine hormone expressed mainly in the liver and is tightly regulated in response to alterations in metabolic or energy status. Overexpression of FGF21 in mice decreased body weight and increased energy expenditure and resistance to HFD-induced obesity, resulting in the improvement of metabolic parameters, including decreased serum lipid and glucose levels.
12 FGF21 −/− mice fed a MCD diet showed significantly exacerbated accumulation of hepatic triglycerides, which are associated with enhanced steatosis, inflammation, and fibrosis. Pharmacologic treatment of FGF21 activates thermogenic genes and browning of white adipose tissue (WAT). We found that CO decreases the body weight, liver weight, and liver damage induced by HFD in FGF21 +/+ mice but not in FGF21 −/− mice. 13 In addition, CO significantly improved glucose tolerance and insulin sensitivity in HFD-fed FGF21 +/+ mice but not in FGF21 −/− mice. Similar to SESN2 expression, treatment with Mito-TEMPO abolished CO-induced mtROS and FGF21 expression, suggesting that FGF21 expression was also upregulated by COgenerated mtROS and the PERK/ATF4 axis. We found that CO reduces adipocyte size with an increase in the thermogenic genes involved in the browning of inguinal WAT in FGF21 +/+ mice fed a HFD compared with FGF21 −/− mice.
ANTITUMOR EFFECTS OF CO-INDUCED REDD1
Hyperactivation and dysregulation of mTORC1 are frequent and common events in various human diseases, including cancer, diabetes, obesity, neurodegenerative disorders, and aging. REDD1 regulates cancer cell growth through cell cycle arrest and apoptosis via mTORC1 inhibition. Moreover, REDD1 was downregulated in some human cancers compared to normal tissues, and treatment with a NEDD8 activating enzyme inhibitor upregulated REDD1 expression to inhibit mTORC1 activity. 14 CO induced the expression of REDD1, and COinduced REDD1 expression was significantly weaker in PERK −/−
MEFs, eIF2α
A/A , and ATF4 −/− hepatocytes compared to wild-type cells, whereas CO-induced REDD1 expression in IRE1α −/− and ATF6 −/− hepatocytes was comparable with that in control cells. In addition, CO-induced REDD1 expression leads to the inhibition of tumor growth and metastatic phenotypes by arresting the cell cycle, and it also induces caspase-8-mediated apoptosis via mTORC1 inactivation. By contrast, knockdown of REDD1 reversed the CO-mediated antitumor effects (Hun Taeg Chung, presented at 2016 KAI-IBS Joint International Conference, 16-18 November 2016).
Several recent studies showed that CO has protective effects against metabolic diseases via induction of ATF4-mediated genes, SESN2, FGF21, and REDD1, suggesting significant roles for CO in metabolic homeostasis (Fig. 1) . It is likely that physiological ROS generated by CO can maintain metabolic health by processes termed mitohormesis as an adaptive response. Moreover, it was shown that ATF4 induced by CO plays key roles in metabolic homeostasis. Based on these findings, CO is a potentially effective strategy to prevent metabolic diseases such as obesity-induced NAFLD, metabolic syndrome, and cancer.
